Showing results (251-260 of 1,380) with videos related to
Sort By:
Pageof 138
Journal of Virology|June 1, 1996
Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediatesA Otteken, P L Earl, B MossCell|April 1, 1975
Methylated nucleotides block 5' terminus of HeLa cell messenger RNAC M Wei, A Gershowitz, B MossJournal of Virology|January 1, 1991
Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: analysis of proteins with truncations and deletions expressed by recombinant vaccinia virusesP L Earl, S Koenig, B MossJournal of Virology|April 5, 2001
Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinaseG R Kovacs, N Vasilakis, B MossThe Journal of Biological Chemistry|June 25, 1975
Characterization of a polyriboadenylate polymerase from vaccinia virionsB Moss, E N Rosenblum, A GershowitzVirology|February 13, 2001
Antibody neutralization of the extracellular enveloped form of vaccinia virusM Law, G L SmithComparative Immunology, Microbiology and Infectious Diseases|September 1, 1996
Soluble interferon-gamma receptors encoded by poxvirusesA Alcamí, G L SmithImmunology Today|October 1, 1995
Cytokine receptors encoded by poxviruses: a lesson in cytokine biologyA Alcamí, G L SmithThe Journal of General Virology|October 1, 1987
Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibodyV Sullivan, G L SmithThe Journal of General Virology|April 1, 1988
The herpes simplex virus type 1 US7 gene product is a 66K glycoprotein and is a target for complement-dependent virus neutralizationV Sullivan, G L SmithPageof 138